Skip to main content

Home-based pulmonary rehabilitation early after hospitalisation in COPD: A randomised controlled trial

In brief

Home-based rehab after COPD admission did not cut 12-month readmissions

In a randomized trial, 60.3% of patients offered home-based rehabilitation were hospitalized again within 12 months, compared with 64.1% receiving usual care - no meaningful difference. The eight-week program had high completion and reduced anxiety, while other benefits appeared among those who completed it compared with patients receiving no rehabilitation; whether it can improve outcomes broadly remains uncertain.

Journal
The European respiratory journal (Q1)
Published
19 November 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Narelle S Cox, Anthony K May, Angela T Burge, Graham Hepworth, Christine F McDonald, Paul O'Halloran, et al.
PMID
43057871
DOI
10.1183/13993003.00985-2026

Why clinicians should know about it

  • Picked for Family Practice (top studies of the week, 22 November 2026): COPD post-discharge home rehabilitation tested against usual care
  • Picked for Pulmonary and Respiratory Medicine (top studies of the week, 22 November 2026): Randomized trial of early home pulmonary rehabilitation after COPD admission
  • Picked for Rehabilitation (top studies of the week, 22 November 2026): Evaluates home-based pulmonary rehabilitation after COPD hospitalization

Abstract

RATIONALE: COPD is characterised by respiratory exacerbations, often requiring hospitalisation. Post-hospitalisation pulmonary rehabilitation (PR) can reduce risk of readmission, but very few people attend PR post exacerbation. OBJECTIVE: To compare hospital readmission rates between people with COPD who undertake a home-based PR program commenced early (≤2 weeks) after hospital discharge (ePR) with usual care. METHODS: Assessor blinded, multi-centre RCT. Participants randomised 1:1 to ePR or usual care. ePR was 8 weeks (1 physiotherapy home-visit, plus 7x weekly phone calls). The primary outcome was all-cause, non-elective hospitalisation at 12 months after rehabilitation completion. RESULTS: From Jan 2020-Jun 2024 157 participants were randomised to ePR (n=77) or usual care (n=80). The ITT analysis included 151 participants (n=73 ePR, n=78 usual care; n=6 excluded: n=5 deceased, n=1 transplant). Rate of all-cause non-elective hospitalisation was not different between groups at 12-month follow-up (ePR 60.3%, usual care 64.1%; RR 0.94 [95%CI 0.73, 1.21]). There was no difference between groups for improvements in quality of life and breathlessness at either time point. There was a clinically and statistically significant reduction in anxiety favouring ePR (10-weeks post-discharge MD -2.1 [95%CI -3.4, -0.8]; 12-months MD -1.6 [95%CI -3.0, -0.2]). ePR completion rate (≥70% sessions) was high (n=57, 74%). When compared to no rehabilitation (per protocol), ePR completers demonstrated significant improvements in breathlessness, quality of life, anxiety/depression and self-efficacy. There was one intervention-related adverse event. CONCLUSION: ePR delivered directly to patients in their homes, commenced within 2 weeks of hospital discharge, did not reduce hospital readmissions over 12 months compared to usual care but did support high program completion. When compared to no rehabilitation, improved clinical outcomes favoured ePR in those who completed the program.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.